1800 202 8726
TB & Inflammation on PET

Can Tuberculosis Look Like — Cancer on a PET Scan?

In India, tuberculosis is one of the most common reasons a PET scan shows a suspicious finding that turns out not to be cancer. Active TB takes up the tracer the same way cancer does — and a scan alone cannot tell them apart.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • TB is genuinely FDG-avid — Active TB lesions take up the tracer because they are sites of intense immune activity, not because of any limitation in the scan.
  • SUV values overlap with cancer — The numbers measured in TB lesions can fall in the same range as those seen in malignancy, which is why the number alone does not answer the question.
  • Appearance alone is not enough — The pattern of uptake can suggest TB to an experienced reader, but it cannot confirm it. Tissue is still required.
  • Both can be present at once — TB and cancer can coexist in the same patient, which is one more reason why a full workup matters before any treatment begins.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Yes. Active tuberculosis takes up FDG and can produce PET findings that look identical to cancer — including high SUV values. This overlap is especially common in India, where TB is endemic. The distinction cannot be made from the scan alone, and tissue sampling is the standard step when the clinical picture is not clear.

CION offers PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.

Does tuberculosis really take up FDG the way cancer does?

Yes. Active TB lesions — in the lungs, lymph nodes, pleura, or elsewhere — take up FDG because they are sites of intense immune and inflammatory activity. Metabolically active cells, whether cancer cells or immune cells fighting infection, all consume glucose in large amounts.

The SUV values measured in active TB can be high, reaching into ranges that overlap with what is seen in malignancy. This is not an error in the scan. It is an accurate reflection of how active the lesion is, and both conditions can produce that level of activity.

In India, where TB is endemic, this overlap is a frequent and well-recognised challenge in PET reporting. A radiologist reading a scan here carries this possibility in mind for every FDG-avid finding.

What will my doctor ask me after a suspicious PET finding?

  • Whether you have had TB before or received treatment for it
  • Whether anyone in your household or close contacts has TB or symptoms of it
  • Whether you have had cough, fever, night sweats, or unexplained weight loss in recent weeks
  • Whether you have had a sputum test, CBNAAT, or IGRA blood test for TB recently, and what the result was
  • Whether you take any medicine that lowers your immune response
  • Whether you have lived in or travelled to an area with high TB rates

How do doctors separate a TB finding from cancer on a PET scan?

They do not — not from the scan alone. PET shows where to look; tissue sampling tells the team what is there.

Your history, your symptoms, and initial investigations narrow the picture first. A positive sputum test, a reactive IGRA, or a pattern of symptoms clearly pointing to TB may allow the team to proceed without a biopsy. When those tests do not resolve the question, a tissue sample is the next step.

Where a biopsy is needed, the team will try to send the same sample for both cancer pathology and TB culture, so both questions are answered from one procedure rather than two.

Do not start TB treatment, change your diet, or take any supplement before discussing it with your treating team. Some choices affect tissue results or drug interactions in ways that matter.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What do the terms on my PET report mean?

FDG (fluorodeoxyglucose)
The radioactive tracer injected before the scan. Cells that consume a lot of glucose — cancer cells, active immune cells, and inflamed tissue — take it up and appear as bright spots on the image.
SUVmax (standardised uptake value, maximum)
A number that measures how intensely a spot has taken up the tracer. A high SUVmax means the area is very metabolically active. It does not identify what type of cells are responsible — both cancer and active TB can produce high values, and the ranges overlap.
FDG-avid
Describes a lesion that takes up more tracer than the surrounding tissue, making it stand out on the scan. An FDG-avid finding is a reason to investigate further. It is not a diagnosis.
Differential diagnosis
The list of conditions that could explain a finding. On PET, the differential for an FDG-avid lesion in India commonly includes cancer, active TB, sarcoidosis, fungal infection, and other inflammatory conditions.
Tissue diagnosis
Taking a small sample from the suspicious area — by biopsy, fine-needle aspiration, or bronchoscopy — and examining it under a microscope. This is usually the only way to confirm what a PET finding represents.

What happens next after a suspicious PET finding?

Your oncologist or pulmonologist will look at the scan alongside your full history and any recent test results. A scan finding does not carry a diagnosis on its own.

In many cases the next steps are simpler tests first: a repeat sputum, a CBNAAT or GeneXpert test, or an IGRA blood test. These take days rather than weeks and can significantly narrow the picture before any procedure is considered.

If a tissue sample is needed, ask your team which type of procedure is planned, what will be tested from the sample, and when results are expected. You deserve a clear answer to each of those questions.

Did you know?

In populations with high TB prevalence, active tuberculosis is one of the most common non-malignant causes of FDG-avid lesions identified during cancer evaluation on PET — and the scan appearance cannot reliably separate the two.

ESNM and SNMMI guidance both note that clinical context and tissue confirmation remain essential steps in TB-endemic settings, precisely because imaging alone is insufficient.

Source: ESNM / SNMMI guidance on FDG PET in infectious and inflammatory conditions

Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.

Explore 94 more Understanding Your PET-CT Report topics

All Understanding Your PET-CT Report →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What does FDG-avid mean on a PET report?

It means the area took up more of the radioactive tracer than the surrounding tissue and stands out as a bright spot on the scan. Both cancer and active infection or inflammation can cause this, because all of them involve cells that are consuming large amounts of glucose. An FDG-avid finding is a signal that something metabolically active is present in that area — it is not a cancer diagnosis. Your team will use it alongside your history and other tests to decide what to do next.

Can the doctor tell from the SUV number whether it is TB or cancer?

No. The SUV measures how intensely an area is taking up the tracer — it does not identify what type of cells are responsible. TB and cancer both produce high SUV values, and the ranges overlap considerably. An experienced reader will consider the pattern of uptake across the whole scan together with your history, your symptoms, and other results. The number alone does not answer the question, and tissue sampling is usually still needed when the clinical picture is not clear.

Will I need a biopsy if my PET shows a suspicious finding?

Not automatically. Your team will usually start with your symptoms, your history, and simpler tests — sputum culture, CBNAAT, or an IGRA blood test for TB — before recommending a procedure. If those tests point clearly toward active TB, the team may start treatment with close monitoring rather than a biopsy. If the picture remains unclear, a tissue sample is the next step. Your oncologist will explain which path applies to your situation and why.

Can TB and cancer both be present at the same time?

Yes, and this happens. TB and cancer can coexist in the same patient. In some cases one condition is found first and the other is identified later during workup. A tissue sample that confirms TB does not automatically rule out cancer elsewhere, and your team will keep both possibilities in view throughout your evaluation. If you develop any new symptom or feel your condition is changing, tell your treating team rather than assuming it is explained by what has already been found.

How long will it take to find out if the finding is TB or cancer?

It depends on which tests are needed. CBNAAT or GeneXpert sputum results can be available within a day or two. TB culture from sputum takes longer. If a biopsy is done, pathology results typically take one to two weeks, and TB culture from biopsy tissue can take several weeks. Ask your team which tests have been sent and what the expected timeline is for each. That is a reasonable question and one they should be able to answer clearly.

Should we ask for a second opinion if the PET report is uncertain?

A second opinion on imaging is always reasonable when a finding is uncertain or the result will drive a major decision. What changes the course of your care more reliably than a second scan reading, however, is tissue confirmation — because two radiologists reading the same scan may still reach different conclusions, while a biopsy result resolves the question directly. Discuss with your treating team whether a repeat read, additional imaging, or a tissue sample is the more useful next step for your specific situation.

Call now Book free consultation